-
L650229-50mgLitronesib (LY2523355) is a selective mitosis-specific kinesin Eg5 inhibitor, with antitumor activityIn VitroLitronesib (LY2523355) is a selective Eg5 inhibitor. Litronesib (25 nM) induces cancer cells to death during mitotic arrest, and this needs
-
L650229-5mgLitronesib (LY2523355) is a selective mitosis-specific kinesin Eg5 inhibitor, with antitumor activityIn VitroLitronesib (LY2523355) is a selective Eg5 inhibitor. Litronesib (25 nM) induces cancer cells to death during mitotic arrest, and this needs
-
L656183-1mlLitronesib (LY2523355) is a selective mitosis-specific kinesin Eg5 inhibitor, with antitumor activityIn VitroLitronesib (LY2523355) is a selective Eg5 inhibitor. Litronesib (25 nM) induces cancer cells to death during mitotic arrest, and this needs
-
L649546-10mgLitronesib Racemate (LY2523355 Racemate) is the racemate of litronesib. Litronesib is a selective, allosteric inhibitor of kinesin Eg5Form:SolidIC50&: Target:kinesin Eg5.
-
L649546-25mgLitronesib Racemate (LY2523355 Racemate) is the racemate of litronesib. Litronesib is a selective, allosteric inhibitor of kinesin Eg5Form:SolidIC50&: Target:kinesin Eg5.
-
L649546-5mgLitronesib Racemate (LY2523355 Racemate) is the racemate of litronesib. Litronesib is a selective, allosteric inhibitor of kinesin Eg5Form:SolidIC50&: Target:kinesin Eg5.
-
L655903-1mlLitronesib Racemate (LY2523355 Racemate) is the racemate of litronesib. Litronesib is a selective, allosteric inhibitor of kinesin Eg5IC50&: Target:kinesin Eg5.
-
L650732-10mgLKY-047, a Decursin derivative, is a potent and selective reversible competitive cytochrome P45022J2 (CYP2J2) inhibitor with an IC 50 of 1.7 μM. LKY-047 is inactive against other human P450s, such as CYPs 1A2, 2A6, 2B6, 2C8, 2C9, 2C19, 2D6, 2E1, and
-
L650732-5mgLKY-047, a Decursin derivative, is a potent and selective reversible competitive cytochrome P45022J2 (CYP2J2) inhibitor with an IC 50 of 1.7 μM. LKY-047 is inactive against other human P450s, such as CYPs 1A2, 2A6, 2B6, 2C8, 2C9, 2C19, 2D6, 2E1, and
-
L649289-10mgLMP744 hydrochloride (MJ-III65 hydrochloride) is a DNA intercalator and Topoisomerase I (Top1) inhibitor with antitumor activityIn VitroThe GI 50 value of LMP744 (MJ-III-65) for NCI60 cells is 0.1 μM. LMP744 (0.1-5 μM, 3 days) induces dose-dependent
-
L649289-1mgLMP744 hydrochloride (MJ-III65 hydrochloride) is a DNA intercalator and Topoisomerase I (Top1) inhibitor with antitumor activityIn VitroThe GI 50 value of LMP744 (MJ-III-65) for NCI60 cells is 0.1 μM. LMP744 (0.1-5 μM, 3 days) induces dose-dependent
-
L649289-50mgLMP744 hydrochloride (MJ-III65 hydrochloride) is a DNA intercalator and Topoisomerase I (Top1) inhibitor with antitumor activityIn VitroThe GI 50 value of LMP744 (MJ-III-65) for NCI60 cells is 0.1 μM. LMP744 (0.1-5 μM, 3 days) induces dose-dependent